Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MGC Pharmaceuticals (GB:MXC)
LSE:MXC
MGC Pharmaceuticals (MXC) Share Price & Analysis
5 Followers
MXC Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range13.10p - 600.00p
Previous Close22p
Volume0.00
Average Volume (3M)28.59K
Market Cap
£9.81M
Enterprise Value9.66M
Total Cash (Recent Filing)AU$239.82K
Total Debt (Recent Filing)AU$575.14K
Price to Earnings (P/E)-0.1
Beta-0.45
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.95
Shares Outstanding43,851,631
10 Day Avg. Volume83,806
30 Day Avg. Volume28,586
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-139.36
Price to Sales (P/S)440.83
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MXC FAQ
What was MGC Pharmaceuticals’s price range in the past 12 months?
MGC Pharmaceuticals lowest share price was 13.10p and its highest was 600.00p in the past 12 months.
What is MGC Pharmaceuticals’s market cap?
Currently, no data Available
When is MGC Pharmaceuticals’s upcoming earnings report date?
MGC Pharmaceuticals’s upcoming earnings report date is Aug 28, 2024 which is in 125 days.
How were MGC Pharmaceuticals’s earnings last quarter?
MGC Pharmaceuticals released its earnings results on Feb 29, 2024. The company reported -15.948p earnings per share for the quarter, missing the consensus estimate of N/A by -15.948p.
Is MGC Pharmaceuticals overvalued?
According to Wall Street analysts MGC Pharmaceuticals’s price is currently Overvalued.
Does MGC Pharmaceuticals pay dividends?
MGC Pharmaceuticals does not currently pay dividends.
What is MGC Pharmaceuticals’s EPS estimate?
MGC Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MGC Pharmaceuticals have?
MGC Pharmaceuticals has 45,280,200 shares outstanding.
What happened to MGC Pharmaceuticals’s price movement after its last earnings report?
MGC Pharmaceuticals reported an EPS of -15.948p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.5%.
Which hedge fund is a major shareholder of MGC Pharmaceuticals?
Currently, no hedge funds are holding shares in GB:MXC
---
MGC Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
14.42%
Trailing 12-Months
Company Description
MGC Pharmaceuticals
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
Technical Analysis
---